دورية أكاديمية

1383P Efficacy of capmatinib compared to standard of care for German patients with locally advanced or metastatic NSCLC harboring METex14 mutations: Results from the RECAP study

التفاصيل البيبلوغرافية
العنوان: 1383P Efficacy of capmatinib compared to standard of care for German patients with locally advanced or metastatic NSCLC harboring METex14 mutations: Results from the RECAP study
المؤلفون: Kron, A., Scheffler, M., Wiesweg, M., Hummel, H-D., Kulhavy, J., Gattenlöhner, S., Kollmeier, J., Schubart, C., Gross, T., Demes, M., Keymel, S., Joosten, M., Merkelbach-Bruse, S., Wölwer, C., Oeser, K., Zehaczek, M., Jeratsch, U., Wolf, J.
المصدر: In Annals of Oncology October 2023 34 Supplement 2:S793-S794
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1016/j.annonc.2023.09.2416